Discovery of an Orally Active Series of Isoxazoline Glycoprotein IIb/IIIa Antagonists
- 1 June 1997
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 40 (13) , 2064-2084
- https://doi.org/10.1021/jm960799i
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Novel nonpeptide antiplatelet glycoprotein llb/llla receptor antagonist, DMP754Coronary Artery Disease, 1996
- Abciximab (c7E3 Fab)Drugs, 1994
- Non-Peptide Fibrinogen Receptor Antagonists. 2. Optimization of a Tyrosine Template as a Mimic for Arg-Gly-AspJournal of Medicinal Chemistry, 1994
- Template-Constrained Cyclic Peptides: Design of High-Affinity Ligands for GPIIb/IIIaJournal of the American Chemical Society, 1994
- Low molecular weight, non-peptide fibrinogen receptor antagonistsJournal of Medicinal Chemistry, 1992
- RGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo. Studies using a baboon model.Journal of Clinical Investigation, 1989
- Mechanisms of signal transduction at the dopamine D2 receptorTrends in Pharmacological Sciences, 1989
- Design of peptide hormone and neurotransmitter analoguesTrends in Pharmacological Sciences, 1985
- Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the .gamma. chainBiochemistry, 1984
- Platelet aggregates in intramyocardial vessels of patients dying suddenly and unexpectedly of coronary artery diseaseAtherosclerosis, 1972